Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
PMAX vs GFAI vs BCO vs CANG vs ARMK
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Security & Protection Services
Auto - Dealerships
Specialty Business Services
PMAX vs GFAI vs BCO vs CANG vs ARMK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Security & Protection Services | Security & Protection Services | Auto - Dealerships | Specialty Business Services |
| Market Cap | $666K | $10M | $4.44B | $250M | $11.84B |
| Revenue (TTM) | $84M | $72M | $5.39B | $3.46B | $18.79B |
| Net Income (TTM) | $-35M | $-24M | $180M | $-178M | $317M |
| Gross Margin | 34.7% | 15.1% | 26.1% | 13.6% | 7.0% |
| Operating Margin | -43.3% | -27.4% | 10.7% | 7.3% | 4.2% |
| Forward P/E | — | — | 11.6x | 5.7x | 20.3x |
| Total Debt | $20M | $3M | $4.93B | $170M | $5.72B |
| Cash & Equiv. | $42M | $22M | $2.27B | $1.29B | $639M |
PMAX vs GFAI vs BCO vs CANG vs ARMK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 24 | May 26 | Return |
|---|---|---|---|
| Powell Max Limited … (PMAX) | 100 | 1.2 | -98.8% |
| Guardforce AI Co., … (GFAI) | 100 | 41.4 | -58.6% |
| The Brink's Company (BCO) | 100 | 92.7 | -7.3% |
| Cango Inc. (CANG) | 100 | 73.3 | -26.7% |
| Aramark (ARMK) | 100 | 116.4 | +16.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PMAX vs GFAI vs BCO vs CANG vs ARMK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PMAX lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, GFAI doesn't own a clear edge in any measured category.
BCO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 6 yrs, beta 1.10, yield 0.9%
- 293.0% 10Y total return vs ARMK's 97.1%
- Beta 1.10, yield 0.9%, current ratio 1.51x
- 3.3% margin vs PMAX's -41.6%
CANG ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 2.25, Low D/E 4.1%, current ratio 1.88x
- Lower P/E (5.7x vs 20.3x)
ARMK is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.4%, EPS growth 23.2%, 3Y rev CAGR 10.6%
- 6.4% revenue growth vs CANG's -52.7%
- Beta 0.71 vs GFAI's 2.31
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.4% revenue growth vs CANG's -52.7% | |
| Value | Lower P/E (5.7x vs 20.3x) | |
| Quality / Margins | 3.3% margin vs PMAX's -41.6% | |
| Stability / Safety | Beta 0.71 vs GFAI's 2.31 | |
| Dividends | 0.9% yield, 6-year raise streak, vs ARMK's 0.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +19.4% vs PMAX's -85.9% | |
| Efficiency (ROA) | 2.5% ROA vs PMAX's -80.7% |
PMAX vs GFAI vs BCO vs CANG vs ARMK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
PMAX vs GFAI vs BCO vs CANG vs ARMK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCO leads in 3 of 6 categories
ARMK leads 2 • PMAX leads 0 • GFAI leads 0 • CANG leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK is the larger business by revenue, generating $18.8B annually — 259.4x GFAI's $72M. BCO is the more profitable business, keeping 3.3% of every revenue dollar as net income compared to PMAX's -41.6%. On growth, CANG holds the edge at +58.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $84M | $72M | $5.4B | $3.5B | $18.8B |
| EBITDAEarnings before interest/tax | -$28M | -$12M | $797M | $333M | $1.3B |
| Net IncomeAfter-tax profit | -$35M | -$24M | $180M | -$178M | $317M |
| Free Cash FlowCash after capex | -$4M | -$6M | $544M | $0 | $257M |
| Gross MarginGross profit ÷ Revenue | +34.7% | +15.1% | +26.1% | +13.6% | +7.0% |
| Operating MarginEBIT ÷ Revenue | -43.3% | -27.4% | +10.7% | +7.3% | +4.2% |
| Net MarginNet income ÷ Revenue | -41.6% | -32.9% | +3.3% | -5.2% | +1.7% |
| FCF MarginFCF ÷ Revenue | -4.8% | -8.8% | +10.1% | -154.0% | +1.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +3.6% | +10.3% | +58.3% | +6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -21.0% | +38.9% | -35.3% | +3.6% | -7.7% |
Valuation Metrics
Evenly matched — GFAI and BCO each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 5.7x trailing earnings, CANG trades at a 85% valuation discount to ARMK's 36.9x P/E. On an enterprise value basis, CANG's 3.1x EV/EBITDA is more attractive than ARMK's 13.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $666,120 | $10M | $4.4B | $250M | $11.8B |
| Enterprise ValueMkt cap + debt − cash | -$2M | -$9M | $7.1B | $85M | $16.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.27x | -0.89x | 22.93x | 5.66x | 36.93x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 11.58x | — | 20.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.38x | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 8.01x | 3.13x | 13.35x |
| Price / SalesMarket cap ÷ Revenue | 0.14x | 0.28x | 0.84x | 2.12x | 0.64x |
| Price / BookPrice ÷ Book value/share | 0.23x | 0.16x | 11.14x | 0.42x | 3.81x |
| Price / FCFMarket cap ÷ FCF | — | — | 10.17x | — | 26.06x |
Profitability & Efficiency
BCO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BCO delivers a 45.6% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-5 for PMAX. CANG carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCO's 12.10x. On the Piotroski fundamental quality scale (0–9), ARMK scores 7/9 vs PMAX's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.9% | -69.7% | +45.6% | -4.1% | +9.8% |
| ROA (TTM)Return on assets | -80.7% | -50.2% | +2.5% | -2.3% | +2.4% |
| ROICReturn on invested capital | — | -41.6% | +14.3% | +4.6% | +7.3% |
| ROCEReturn on capital employed | -4.3% | -19.1% | +12.1% | +4.5% | +8.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 6 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.94x | 0.08x | 12.10x | 0.04x | 1.81x |
| Net DebtTotal debt minus cash | -$22M | -$19M | $2.7B | -$1.1B | $5.1B |
| Cash & Equiv.Liquid assets | $42M | $22M | $2.3B | $1.3B | $639M |
| Total DebtShort + long-term debt | $20M | $3M | $4.9B | $170M | $5.7B |
| Interest CoverageEBIT ÷ Interest expense | -90.56x | -167.24x | 3.90x | -1.87x | 2.20x |
Total Returns (Dividends Reinvested)
ARMK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMK five years ago would be worth $17,052 today (with dividends reinvested), compared to $46 for GFAI. Over the past 12 months, BCO leads with a +19.4% total return vs PMAX's -85.9%. The 3-year compound annual growth rate (CAGR) favors ARMK at 23.3% vs PMAX's -76.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -78.9% | -26.3% | -7.3% | -62.0% | +23.5% |
| 1-Year ReturnPast 12 months | -85.9% | -53.2% | +19.4% | -73.7% | +19.0% |
| 3-Year ReturnCumulative with dividends | -98.7% | -93.8% | +75.3% | +1.2% | +87.4% |
| 5-Year ReturnCumulative with dividends | -98.7% | -99.5% | +39.3% | -14.2% | +70.5% |
| 10-Year ReturnCumulative with dividends | -98.7% | -99.5% | +293.0% | -44.9% | +97.1% |
| CAGR (3Y)Annualised 3-year return | -76.4% | -60.4% | +20.6% | +0.4% | +23.3% |
Risk & Volatility
ARMK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ARMK is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ARMK currently trades 96.1% from its 52-week high vs PMAX's 4.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.48x | 2.36x | 1.12x | 2.49x | 0.78x |
| 52-Week HighHighest price in past year | $89.60 | $1.50 | $136.37 | $2.88 | $46.88 |
| 52-Week LowLowest price in past year | $1.90 | $0.38 | $80.10 | $0.33 | $35.07 |
| % of 52W HighCurrent price vs 52-week peak | +4.7% | +31.5% | +79.0% | +18.6% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 54.5 | 47.0 | 52.0 | 58.6 | 62.0 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 378K | 543K | 1.3M | 2.2M |
Analyst Outlook
BCO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCO as "Buy", CANG as "Buy", ARMK as "Buy". Consensus price targets imply 459.2% upside for CANG (target: $3) vs 4.7% for ARMK (target: $47). For income investors, BCO offers the higher dividend yield at 0.93% vs ARMK's 0.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $163.00 | $3.00 | $47.20 |
| # AnalystsCovering analysts | — | — | 9 | 2 | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.9% | — | +0.9% |
| Dividend StreakConsecutive years of raises | — | — | 6 | 5 | 1 |
| Dividend / ShareAnnual DPS | — | — | $1.00 | — | $0.41 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.7% | +5.3% | +1.2% |
BCO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARMK leads in 2 (Total Returns, Risk & Volatility). 1 tied.
PMAX vs GFAI vs BCO vs CANG vs ARMK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PMAX or GFAI or BCO or CANG or ARMK a better buy right now?
For growth investors, Aramark (ARMK) is the stronger pick with 6.
4% revenue growth year-over-year, versus -52. 7% for Cango Inc. (CANG). Cango Inc. (CANG) offers the better valuation at 5. 7x trailing P/E, making it the more compelling value choice. Analysts rate The Brink's Company (BCO) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PMAX or GFAI or BCO or CANG or ARMK?
On trailing P/E, Cango Inc.
(CANG) is the cheapest at 5. 7x versus Aramark at 36. 9x. On forward P/E, The Brink's Company is actually cheaper at 11. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PMAX or GFAI or BCO or CANG or ARMK?
Over the past 5 years, Aramark (ARMK) delivered a total return of +70.
5%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: BCO returned +291. 2% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PMAX or GFAI or BCO or CANG or ARMK?
By beta (market sensitivity over 5 years), Aramark (ARMK) is the lower-risk stock at 0.
78β versus Cango Inc. 's 2. 49β — meaning CANG is approximately 220% more volatile than ARMK relative to the S&P 500. On balance sheet safety, Cango Inc. (CANG) carries a lower debt/equity ratio of 4% versus 12% for The Brink's Company — giving it more financial flexibility in a downturn.
05Which is growing faster — PMAX or GFAI or BCO or CANG or ARMK?
By revenue growth (latest reported year), Aramark (ARMK) is pulling ahead at 6.
4% versus -52. 7% for Cango Inc. (CANG). On earnings-per-share growth, the picture is similar: Cango Inc. grew EPS 960. 0% year-over-year, compared to -350. 8% for Powell Max Limited Class A Ordinary Shares. Over a 3-year CAGR, ARMK leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PMAX or GFAI or BCO or CANG or ARMK?
Cango Inc.
(CANG) is the more profitable company, earning 37. 3% net margin versus -49. 6% for Powell Max Limited Class A Ordinary Shares — meaning it keeps 37. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CANG leads at 22. 2% versus -49. 3% for PMAX. At the gross margin level — before operating expenses — CANG leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PMAX or GFAI or BCO or CANG or ARMK more undervalued right now?
On forward earnings alone, The Brink's Company (BCO) trades at 11.
6x forward P/E versus 20. 3x for Aramark — 8. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CANG: 459. 2% to $3. 00.
08Which pays a better dividend — PMAX or GFAI or BCO or CANG or ARMK?
In this comparison, BCO (0.
9% yield), ARMK (0. 9% yield) pay a dividend. PMAX, GFAI, CANG do not pay a meaningful dividend and should not be held primarily for income.
09Is PMAX or GFAI or BCO or CANG or ARMK better for a retirement portfolio?
For long-horizon retirement investors, Aramark (ARMK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
78), 0. 9% yield). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 36 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ARMK: +97. 2%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PMAX and GFAI and BCO and CANG and ARMK?
These companies operate in different sectors (PMAX (Industrials) and GFAI (Industrials) and BCO (Industrials) and CANG (Consumer Cyclical) and ARMK (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PMAX is a small-cap quality compounder stock; GFAI is a small-cap quality compounder stock; BCO is a small-cap quality compounder stock; CANG is a small-cap deep-value stock; ARMK is a mid-cap quality compounder stock. BCO, ARMK pay a dividend while PMAX, GFAI, CANG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.